INIS
patients
100%
liver
94%
hepatitis
71%
diseases
50%
therapy
37%
quality of life
27%
safety
19%
risks
17%
surveys
14%
management
14%
females
11%
symptoms
9%
sex
9%
reviews
9%
death
9%
volume
9%
tumors
8%
netherlands
8%
prednisolone
8%
data
8%
induction
7%
pregnancy
7%
comparative evaluations
7%
evaluation
7%
applications
6%
cysts
6%
males
6%
injuries
6%
erbium nitrides
6%
levels
6%
Keyphrases
Autoimmune Hepatitis
69%
Biochemical Response
26%
Health-related Quality of Life
25%
Polycystic Liver Disease
24%
International Autoimmune Hepatitis Group (IAIHG)
24%
Autoimmune Liver Disease
19%
Liver Transplantation
17%
Liver
15%
Mycophenolate Mofetil
15%
Randomized Controlled Trial
13%
Risk Factors
12%
Adverse Outcomes
12%
Multicenter Randomized Controlled Trial
12%
Cholestatic Liver Disease
12%
Safety Profile
12%
Immune Checkpoint Therapy
12%
PD-1/PD-L1 Immune Checkpoint
12%
Quality of Life
9%
Prednisolone
9%
Primary Biliary Cholangitis
8%
Netherlands
8%
Total Liver Volume
8%
Online Survey
8%
IrAE
8%
Cirrhosis
8%
Immunosuppression
7%
Treatment-naïve
7%
Decompensated Cirrhosis
7%
Clinical Management
6%
Incomplete Response
6%
Medicine and Dentistry
Autoimmune Hepatitis
51%
Liver Polycystic Disease
24%
Quality of Life
21%
Liver Transplantation
15%
Adverse Outcome
12%
Liver Disease
12%
Randomized Controlled Trial
12%
Programmed Death-Ligand 1
12%
Immunosuppressive Treatment
7%
Decompensated Liver Cirrhosis
7%
Liver Cirrhosis
6%
Diseases
6%
Clinical Management
6%
Combination Therapy
6%
Liver Tumor
6%
Hepatomegaly
6%
Liver Cyst
6%
Patient Referral
6%
Autoimmune Liver Disease
6%
Hernia
6%
Liver Injury
6%
Tacrolimus
6%
Mycophenolic Acid
6%
Abdominal Wall Hernia
6%
Machine Perfusion
6%
Hepatocellular Adenoma
6%
Systematic Review
6%
SARS Coronavirus
6%
Infection
6%
Alpha 1-Antitrypsin Deficiency
6%
